Tissue-specific alternative splicing of the CSE1L/CAS (cellular apoptosis susceptibility) gene

被引:10
|
作者
Brinkmann, U [1 ]
Brinkmann, E [1 ]
Bera, TK [1 ]
Wellmann, A [1 ]
Pastan, I [1 ]
机构
[1] NCI, Mol Biol Lab, DBS, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1006/geno.1998.5700
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
CSE1L/CAS (CAS) is a nuclear transport factor that plays a role in proliferation and apoptosis. The CAS gene consists of 25 exons. mRNA homologous over its entire length to the yeast homologue CSE1 is the predominant transcript in proliferating tissues. Additional mRNAs are generated by alternative splicing in a tissue-specific manner. An extended 3'-end is found in fetal and adult brain, A mRNA containing the 5'-end of CAS up to position 690 and an alternative 3'-end is expressed in trachea and encodes a truncated Ran-binding domain. Fetal liver expresses a mRNA with deletions of a central portion of CAS and additional sequences encoded by the last intron, SW480 colon cancer cells express another similar to 1500-base mRNA. Western blot analyses of various human tissues and immunohistology of mouse embryos show a correlation of CAS transcripts and CAS protein in different tissues, CAS isoforms may control nuclear transport of tissue-specific proteins.
引用
收藏
页码:41 / 49
页数:9
相关论文
共 50 条
  • [1] Cellular apoptosis susceptibility (CSE1L/CAS) protein in cancer metastasis and chemotherapeutic drug-induced apoptosis
    Tai, Cheng-Jeng
    Hsu, Chung-Huei
    Shen, Shing-Chuan
    Lee, Woan-Ruoh
    Jiang, Ming-Chung
    [J]. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2010, 29
  • [2] Cellular apoptosis susceptibility (CSE1L/CAS) protein in cancer metastasis and chemotherapeutic drug-induced apoptosis
    Cheng-Jeng Tai
    Chung-Huei Hsu
    Shing-Chuan Shen
    Woan-Ruoh Lee
    Ming-Chung Jiang
    [J]. Journal of Experimental & Clinical Cancer Research, 29
  • [3] CSE1L/CAS, the cellular apoptosis susceptibility protein, enhances invasion and metastasis but not proliferation of cancer cells
    Ching-Fong Liao
    Shue-Fen Luo
    Li-Tzu Li
    Chuang-Yu Lin
    Ying-Chun Chen
    Ming-Chung Jiang
    [J]. Journal of Experimental & Clinical Cancer Research, 27
  • [4] CSE1L/CAS: Its role in proliferation and apoptosis
    Behrens, P
    Brinkmann, U
    Wellmann, A
    [J]. APOPTOSIS, 2003, 8 (01) : 39 - 44
  • [5] CSE1L/CAS: Its role in proliferation and apoptosis
    P. Behrens
    U. Brinkmann
    A. Wellmann
    [J]. Apoptosis, 2003, 8 : 39 - 44
  • [6] Expression of CAS/CSE1L, the Cellular Apoptosis Susceptibility Protein, Correlates With Neoplastic Progression in Barrett's Esophagus
    Jiang, Kun
    Cowden, Daniel
    Neill, Kevin G.
    Klapman, Jason B.
    Eschrich, Steven
    Pimiento, Jose M.
    Malafa, Mokenge P.
    Coppola, Domenico
    [J]. GASTROENTEROLOGY, 2016, 150 (04) : S482 - S483
  • [7] Expression of CAS/CSE1L, the Cellular Apoptosis Susceptibility Protein, Correlates With Neoplastic Progression in Barrett's Esophagus
    Jiang, Kun
    Neill, Kevin
    Cowden, Daniel
    Klapman, Jason
    Eschrich, Steven
    Pimiento, Jose
    Malafa, Mokenge P.
    Coppola, Domenico
    [J]. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2018, 26 (08) : 552 - 556
  • [8] The cellular apoptosis susceptibility CAS/CSE1L gene protects ovarian cancer cells from death by suppressing RASSF1C
    Lorenzato, Annalisa
    Martino, Cosimo
    Dani, Nadia
    Oligschlaeger, Yvonne
    Ferrero, Anna Maria
    Biglia, Nicoletta
    Calogero, Raffaele
    Olivero, Martina
    Di Renzo, Maria Flavia
    [J]. FASEB JOURNAL, 2012, 26 (06): : 2446 - 2456
  • [9] Suppression of Cellular Apoptosis Susceptibility (CSE1L) Inhibits Proliferation and Induces Apoptosis in Colorectal Cancer Cells
    Zhu, Jin-Hui
    Hong, De-Fei
    Song, Yong-Mao
    Sun, Li-Feng
    Wang, Zhi-Fei
    Wang, Jian-Wei
    [J]. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (02) : 1017 - 1021
  • [10] Implication of the proliferation and apoptosis associated CSE1L/CAS gene for breast cancer development
    Behrens, P
    Brinkmann, U
    Fogt, F
    Wernert, N
    Wellmann, A
    [J]. ANTICANCER RESEARCH, 2001, 21 (4A) : 2413 - 2417